Overview of Malaria Chemoprophylaxis

Dr. Anne McCarthy (University of Ottawa, Department of Medicine)

Dr. Anne McCarthy is Professor of Medicine at the University of Ottawa and a member of the Division of Infectious Diseases at the Ottawa Hospital. She is actively involved in Tropical Medicine and International Health including the development of prevention and treatment strategies for malaria and recommendations for travel related vaccine preventable diseases. Dr. McCarthy is the National Coordinator of the Canadian Malaria Network in collaboration with Health Canada’s Travel Medicine Program and chairs the Committee to Advise on Tropical Medicine and Travel.

Her educational interests include undergraduate and postgraduate medical teaching in infectious disease, travel medicine, tropical medicine and international health. Her clinical interests include directing the Tropical Medicine and International Health Clinic at the General Campus, clinical infectious diseases with emphasis on infections in the intensive care unit, transplant patients, as well as malaria and tuberculosis.

Her research interests include studies on antimalarial drugs - including tolerability and interactions with concurrent medication (such as antiretroviral drugs for HIV), vaccine efficacy, compliance with travel medicine recommendations, and health issues related to migration.


  • Describe epidemiology of malaria.
  • Describe vector and cycle of malaria infection.
  • Discuss the rational for using chemoprophylaxis for malaria.
  • Explain the best choices of malaria chemoprophylaxis for travelers with different travel itineraries.